Fadraciclib

Fadraciclib
Item number Size Datasheet Manual SDS Delivery time Quantity Price
TGM-TQ0053-1mg 1 mg

7 - 10 business days*

67.00€
TGM-TQ0053-5mg 5 mg

7 - 10 business days*

168.00€
TGM-TQ0053-1mL 1 ml

7 - 10 business days*

184.00€
TGM-TQ0053-10mg 10 mg

7 - 10 business days*

306.00€
TGM-TQ0053-25mg 25 mg

7 - 10 business days*

522.00€
TGM-TQ0053-50mg 50 mg

7 - 10 business days*

752.00€
TGM-TQ0053-100mg 100 mg

7 - 10 business days*

1,059.00€
 
Description: Fadraciclib (CYC065) is an orally available, second-generation ATP-competitive... more
Product information "Fadraciclib"
Description: Fadraciclib (CYC065) is an orally available, second-generation ATP-competitive inhibitor of CDK2/CDK9 kinases (IC50s: 5/26 nM). Target: CDK. Smiles: CC[C@H](Nc1nc(NCc2cnc(C)cc2C)c2ncn(C(C)C)c2n1)[C@@H](C)O. References: Cocco E, et al. Dual CCNE1/PIK3CA targeting is synergistic in CCNE1-amplified/PIK3CA-mutated uterine serous carcinomas in vitro and in vivo. Br J Cancer. 2016 Jul 26,115(3):303-11.
Keywords: CYC065
Supplier: TargetMol
Supplier-Nr: TQ0053

Properties

Application: Cdk2 / Cdk9 inhibitor
MW: 397.52 D
Formula: C21H31N7O

Database Information

CAS : 1070790-89-4| Matching products
KEGG ID : K02206 | Matching products

Handling & Safety

Storage: +4°C
Shipping: +4°C (International: +4°C)
Caution
Our products are for laboratory research use only: Not for administration to humans!
Information about the product reference will follow. more
You will get a certificate here
or to request a certificate of analysis.
Read, write and discuss reviews... more
Customer review for "Fadraciclib"
Write a review
or to review a product.
Viewed